nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—HRH1—atherosclerosis	0.595	1	CbGaD
Prochlorperazine—CYP2D6—Niacin—atherosclerosis	0.0422	0.169	CbGbCtD
Prochlorperazine—CYP2D6—Simvastatin—atherosclerosis	0.0334	0.134	CbGbCtD
Prochlorperazine—CYP2D6—Pravastatin—atherosclerosis	0.0327	0.131	CbGbCtD
Prochlorperazine—CYP2D6—Lovastatin—atherosclerosis	0.0327	0.131	CbGbCtD
Prochlorperazine—CYP3A4—Ezetimibe—atherosclerosis	0.0228	0.0915	CbGbCtD
Prochlorperazine—CYP3A4—Rosuvastatin—atherosclerosis	0.0228	0.0915	CbGbCtD
Prochlorperazine—CYP3A4—Simvastatin—atherosclerosis	0.0212	0.0851	CbGbCtD
Prochlorperazine—CYP3A4—Lovastatin—atherosclerosis	0.0208	0.0833	CbGbCtD
Prochlorperazine—CYP3A4—Pravastatin—atherosclerosis	0.0208	0.0833	CbGbCtD
Prochlorperazine—Systemic lupus erythematosus—Lovastatin—atherosclerosis	0.00215	0.021	CcSEcCtD
Prochlorperazine—Pregnancy—Lovastatin—atherosclerosis	0.00209	0.0205	CcSEcCtD
Prochlorperazine—Systemic lupus erythematosus—Simvastatin—atherosclerosis	0.00201	0.0196	CcSEcCtD
Prochlorperazine—Pregnancy—Simvastatin—atherosclerosis	0.00196	0.0191	CcSEcCtD
Prochlorperazine—Systemic lupus erythematosus—Pravastatin—atherosclerosis	0.00182	0.0177	CcSEcCtD
Prochlorperazine—Blood disorder—Rosuvastatin—atherosclerosis	0.00168	0.0164	CcSEcCtD
Prochlorperazine—Laryngeal oedema—Niacin—atherosclerosis	0.00159	0.0155	CcSEcCtD
Prochlorperazine—Laryngospasm—Niacin—atherosclerosis	0.00137	0.0134	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Lovastatin—atherosclerosis	0.00135	0.0132	CcSEcCtD
Prochlorperazine—Cholestasis—Niacin—atherosclerosis	0.00134	0.0131	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Simvastatin—atherosclerosis	0.00127	0.0124	CcSEcCtD
Prochlorperazine—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00125	0.0123	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Ezetimibe—atherosclerosis	0.00117	0.0114	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Niacin—atherosclerosis	0.00116	0.0114	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Pravastatin—atherosclerosis	0.00114	0.0112	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Simvastatin—atherosclerosis	0.00111	0.0109	CcSEcCtD
Prochlorperazine—Gynaecomastia—Lovastatin—atherosclerosis	0.00106	0.0104	CcSEcCtD
Prochlorperazine—Dermatitis contact—Niacin—atherosclerosis	0.00101	0.00986	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Pravastatin—atherosclerosis	0.00101	0.00982	CcSEcCtD
Prochlorperazine—Gynaecomastia—Simvastatin—atherosclerosis	0.000995	0.00972	CcSEcCtD
Prochlorperazine—Photosensitivity—Lovastatin—atherosclerosis	0.000983	0.0096	CcSEcCtD
Prochlorperazine—Photosensitivity—Ezetimibe—atherosclerosis	0.000964	0.00942	CcSEcCtD
Prochlorperazine—Haemolytic anaemia—Lovastatin—atherosclerosis	0.000956	0.00934	CcSEcCtD
Prochlorperazine—Photosensitivity—Simvastatin—atherosclerosis	0.000919	0.00898	CcSEcCtD
Prochlorperazine—Gynaecomastia—Pravastatin—atherosclerosis	0.000899	0.00879	CcSEcCtD
Prochlorperazine—Eczema—Simvastatin—atherosclerosis	0.000898	0.00877	CcSEcCtD
Prochlorperazine—Haemolytic anaemia—Simvastatin—atherosclerosis	0.000894	0.00873	CcSEcCtD
Prochlorperazine—Influenza—Rosuvastatin—atherosclerosis	0.00088	0.0086	CcSEcCtD
Prochlorperazine—Photosensitivity—Pravastatin—atherosclerosis	0.000831	0.00812	CcSEcCtD
Prochlorperazine—Eczema—Niacin—atherosclerosis	0.000825	0.00806	CcSEcCtD
Prochlorperazine—Haemolytic anaemia—Pravastatin—atherosclerosis	0.000808	0.0079	CcSEcCtD
Prochlorperazine—Jaundice—Rosuvastatin—atherosclerosis	0.000765	0.00747	CcSEcCtD
Prochlorperazine—Influenza—Lovastatin—atherosclerosis	0.000746	0.00729	CcSEcCtD
Prochlorperazine—Eosinophilia—Lovastatin—atherosclerosis	0.000738	0.00721	CcSEcCtD
Prochlorperazine—Influenza—Ezetimibe—atherosclerosis	0.000731	0.00715	CcSEcCtD
Prochlorperazine—Eosinophilia—Ezetimibe—atherosclerosis	0.000724	0.00708	CcSEcCtD
Prochlorperazine—Urinary retention—Niacin—atherosclerosis	0.000705	0.00688	CcSEcCtD
Prochlorperazine—Eosinophilia—Simvastatin—atherosclerosis	0.000691	0.00675	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Lovastatin—atherosclerosis	0.000687	0.00671	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000681	0.00665	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000674	0.00658	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000668	0.00652	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Simvastatin—atherosclerosis	0.000642	0.00628	CcSEcCtD
Prochlorperazine—Influenza—Niacin—atherosclerosis	0.000641	0.00626	CcSEcCtD
Prochlorperazine—Dysphagia—Niacin—atherosclerosis	0.000641	0.00626	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000637	0.00622	CcSEcCtD
Prochlorperazine—Jaundice—Ezetimibe—atherosclerosis	0.000636	0.00621	CcSEcCtD
Prochlorperazine—Influenza—Pravastatin—atherosclerosis	0.000631	0.00616	CcSEcCtD
Prochlorperazine—Arrhythmia—Rosuvastatin—atherosclerosis	0.000629	0.00615	CcSEcCtD
Prochlorperazine—Eosinophilia—Pravastatin—atherosclerosis	0.000624	0.0061	CcSEcCtD
Prochlorperazine—Jaundice—Simvastatin—atherosclerosis	0.000606	0.00592	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Niacin—atherosclerosis	0.00059	0.00576	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Pravastatin—atherosclerosis	0.000581	0.00567	CcSEcCtD
Prochlorperazine—Oedema peripheral—Ezetimibe—atherosclerosis	0.000577	0.00563	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000576	0.00562	CcSEcCtD
Prochlorperazine—Weight increased—Pravastatin—atherosclerosis	0.000574	0.00561	CcSEcCtD
Prochlorperazine—Erythema multiforme—Lovastatin—atherosclerosis	0.000564	0.00551	CcSEcCtD
Prochlorperazine—Angioedema—Rosuvastatin—atherosclerosis	0.00056	0.00547	CcSEcCtD
Prochlorperazine—Jaundice—Niacin—atherosclerosis	0.000557	0.00544	CcSEcCtD
Prochlorperazine—Erythema multiforme—Ezetimibe—atherosclerosis	0.000554	0.00541	CcSEcCtD
Prochlorperazine—Jaundice—Pravastatin—atherosclerosis	0.000548	0.00535	CcSEcCtD
Prochlorperazine—Cough—Rosuvastatin—atherosclerosis	0.000535	0.00523	CcSEcCtD
Prochlorperazine—Erythema multiforme—Simvastatin—atherosclerosis	0.000528	0.00516	CcSEcCtD
Prochlorperazine—Cetirizine—HRH1—atherosclerosis	0.000515	0.0762	CrCbGaD
Prochlorperazine—Erythema—Ezetimibe—atherosclerosis	0.00051	0.00498	CcSEcCtD
Prochlorperazine—Oedema peripheral—Niacin—atherosclerosis	0.000505	0.00493	CcSEcCtD
Prochlorperazine—Muscle spasms—Lovastatin—atherosclerosis	0.0005	0.00488	CcSEcCtD
Prochlorperazine—Infection—Rosuvastatin—atherosclerosis	0.000497	0.00486	CcSEcCtD
Prochlorperazine—Muscle spasms—Ezetimibe—atherosclerosis	0.00049	0.00479	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00049	0.00479	CcSEcCtD
Prochlorperazine—Vision blurred—Lovastatin—atherosclerosis	0.00049	0.00478	CcSEcCtD
Prochlorperazine—Tremor—Lovastatin—atherosclerosis	0.000487	0.00476	CcSEcCtD
Prochlorperazine—Erythema—Simvastatin—atherosclerosis	0.000486	0.00475	CcSEcCtD
Prochlorperazine—Erythema multiforme—Pravastatin—atherosclerosis	0.000477	0.00466	CcSEcCtD
Prochlorperazine—Angioedema—Lovastatin—atherosclerosis	0.000475	0.00464	CcSEcCtD
Prochlorperazine—Chlorcyclizine—HRH1—atherosclerosis	0.00047	0.0695	CrCbGaD
Prochlorperazine—Muscle spasms—Simvastatin—atherosclerosis	0.000467	0.00457	CcSEcCtD
Prochlorperazine—Angioedema—Ezetimibe—atherosclerosis	0.000466	0.00455	CcSEcCtD
Prochlorperazine—Leukopenia—Lovastatin—atherosclerosis	0.000465	0.00454	CcSEcCtD
Prochlorperazine—Vision blurred—Simvastatin—atherosclerosis	0.000458	0.00447	CcSEcCtD
Prochlorperazine—Arrhythmia—Niacin—atherosclerosis	0.000458	0.00447	CcSEcCtD
Prochlorperazine—Tremor—Simvastatin—atherosclerosis	0.000455	0.00445	CcSEcCtD
Prochlorperazine—Insomnia—Rosuvastatin—atherosclerosis	0.000453	0.00442	CcSEcCtD
Prochlorperazine—Arrhythmia—Pravastatin—atherosclerosis	0.000451	0.00441	CcSEcCtD
Prochlorperazine—Erythema—Niacin—atherosclerosis	0.000446	0.00436	CcSEcCtD
Prochlorperazine—Aceprometazine—HRH1—atherosclerosis	0.000446	0.066	CrCbGaD
Prochlorperazine—Cough—Ezetimibe—atherosclerosis	0.000445	0.00434	CcSEcCtD
Prochlorperazine—Angioedema—Simvastatin—atherosclerosis	0.000444	0.00434	CcSEcCtD
Prochlorperazine—Leukopenia—Simvastatin—atherosclerosis	0.000435	0.00425	CcSEcCtD
Prochlorperazine—Nervousness—Niacin—atherosclerosis	0.000433	0.00423	CcSEcCtD
Prochlorperazine—Dry mouth—Lovastatin—atherosclerosis	0.000433	0.00423	CcSEcCtD
Prochlorperazine—Meclizine—HRH1—atherosclerosis	0.000431	0.0637	CrCbGaD
Prochlorperazine—Muscle spasms—Niacin—atherosclerosis	0.000429	0.00419	CcSEcCtD
Prochlorperazine—Constipation—Rosuvastatin—atherosclerosis	0.000428	0.00418	CcSEcCtD
Prochlorperazine—Nervousness—Pravastatin—atherosclerosis	0.000427	0.00417	CcSEcCtD
Prochlorperazine—Dry mouth—Ezetimibe—atherosclerosis	0.000424	0.00415	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000424	0.00414	CcSEcCtD
Prochlorperazine—Muscle spasms—Pravastatin—atherosclerosis	0.000422	0.00413	CcSEcCtD
Prochlorperazine—Infection—Lovastatin—atherosclerosis	0.000421	0.00412	CcSEcCtD
Prochlorperazine—Vision blurred—Niacin—atherosclerosis	0.000421	0.00411	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000416	0.00406	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000415	0.00406	CcSEcCtD
Prochlorperazine—Vision blurred—Pravastatin—atherosclerosis	0.000414	0.00405	CcSEcCtD
Prochlorperazine—Infection—Ezetimibe—atherosclerosis	0.000413	0.00404	CcSEcCtD
Prochlorperazine—Methdilazine—HRH1—atherosclerosis	0.000413	0.0611	CrCbGaD
Prochlorperazine—Tremor—Pravastatin—atherosclerosis	0.000412	0.00402	CcSEcCtD
Prochlorperazine—Angioedema—Niacin—atherosclerosis	0.000408	0.00398	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000407	0.00398	CcSEcCtD
Prochlorperazine—Skin disorder—Ezetimibe—atherosclerosis	0.000404	0.00395	CcSEcCtD
Prochlorperazine—Angioedema—Pravastatin—atherosclerosis	0.000402	0.00392	CcSEcCtD
Prochlorperazine—Leukopenia—Niacin—atherosclerosis	0.000399	0.0039	CcSEcCtD
Prochlorperazine—Hydroxyzine—HRH1—atherosclerosis	0.000398	0.0588	CrCbGaD
Prochlorperazine—Urticaria—Rosuvastatin—atherosclerosis	0.000398	0.00388	CcSEcCtD
Prochlorperazine—Oedema—Simvastatin—atherosclerosis	0.000397	0.00388	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000397	0.00388	CcSEcCtD
Prochlorperazine—Infection—Simvastatin—atherosclerosis	0.000394	0.00385	CcSEcCtD
Prochlorperazine—Leukopenia—Pravastatin—atherosclerosis	0.000393	0.00384	CcSEcCtD
Prochlorperazine—Cough—Niacin—atherosclerosis	0.000389	0.0038	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000388	0.00379	CcSEcCtD
Prochlorperazine—Insomnia—Lovastatin—atherosclerosis	0.000384	0.00375	CcSEcCtD
Prochlorperazine—Cough—Pravastatin—atherosclerosis	0.000383	0.00375	CcSEcCtD
Prochlorperazine—Dyspnoea—Lovastatin—atherosclerosis	0.000378	0.00369	CcSEcCtD
Prochlorperazine—Insomnia—Ezetimibe—atherosclerosis	0.000376	0.00368	CcSEcCtD
Prochlorperazine—Dry mouth—Niacin—atherosclerosis	0.000372	0.00363	CcSEcCtD
Prochlorperazine—Dyspnoea—Ezetimibe—atherosclerosis	0.000371	0.00362	CcSEcCtD
Prochlorperazine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000369	0.0036	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Niacin—atherosclerosis	0.000364	0.00356	CcSEcCtD
Prochlorperazine—Oedema—Niacin—atherosclerosis	0.000364	0.00356	CcSEcCtD
Prochlorperazine—Constipation—Lovastatin—atherosclerosis	0.000363	0.00354	CcSEcCtD
Prochlorperazine—Insomnia—Simvastatin—atherosclerosis	0.000359	0.0035	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000359	0.0035	CcSEcCtD
Prochlorperazine—Oedema—Pravastatin—atherosclerosis	0.000359	0.0035	CcSEcCtD
Prochlorperazine—Infection—Pravastatin—atherosclerosis	0.000356	0.00348	CcSEcCtD
Prochlorperazine—Constipation—Ezetimibe—atherosclerosis	0.000356	0.00347	CcSEcCtD
Prochlorperazine—Pruritus—Rosuvastatin—atherosclerosis	0.000354	0.00346	CcSEcCtD
Prochlorperazine—Skin disorder—Niacin—atherosclerosis	0.000354	0.00346	CcSEcCtD
Prochlorperazine—Dyspnoea—Simvastatin—atherosclerosis	0.000354	0.00345	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000351	0.00343	CcSEcCtD
Prochlorperazine—Hypotension—Niacin—atherosclerosis	0.00034	0.00332	CcSEcCtD
Prochlorperazine—Constipation—Simvastatin—atherosclerosis	0.000339	0.00331	CcSEcCtD
Prochlorperazine—Urticaria—Lovastatin—atherosclerosis	0.000337	0.00329	CcSEcCtD
Prochlorperazine—Body temperature increased—Lovastatin—atherosclerosis	0.000335	0.00328	CcSEcCtD
Prochlorperazine—Dizziness—Rosuvastatin—atherosclerosis	0.000331	0.00323	CcSEcCtD
Prochlorperazine—Urticaria—Ezetimibe—atherosclerosis	0.00033	0.00323	CcSEcCtD
Prochlorperazine—Insomnia—Niacin—atherosclerosis	0.000329	0.00322	CcSEcCtD
Prochlorperazine—Body temperature increased—Ezetimibe—atherosclerosis	0.000329	0.00321	CcSEcCtD
Prochlorperazine—Dyspnoea—Niacin—atherosclerosis	0.000325	0.00317	CcSEcCtD
Prochlorperazine—Insomnia—Pravastatin—atherosclerosis	0.000324	0.00317	CcSEcCtD
Prochlorperazine—Somnolence—Niacin—atherosclerosis	0.000324	0.00316	CcSEcCtD
Prochlorperazine—Dyspnoea—Pravastatin—atherosclerosis	0.00032	0.00312	CcSEcCtD
Prochlorperazine—Rash—Rosuvastatin—atherosclerosis	0.000316	0.00308	CcSEcCtD
Prochlorperazine—Dermatitis—Rosuvastatin—atherosclerosis	0.000315	0.00308	CcSEcCtD
Prochlorperazine—Urticaria—Simvastatin—atherosclerosis	0.000315	0.00308	CcSEcCtD
Prochlorperazine—Body temperature increased—Simvastatin—atherosclerosis	0.000314	0.00306	CcSEcCtD
Prochlorperazine—Headache—Rosuvastatin—atherosclerosis	0.000314	0.00306	CcSEcCtD
Prochlorperazine—Hypersensitivity—Lovastatin—atherosclerosis	0.000312	0.00305	CcSEcCtD
Prochlorperazine—Constipation—Pravastatin—atherosclerosis	0.000307	0.003	CcSEcCtD
Prochlorperazine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000306	0.00299	CcSEcCtD
Prochlorperazine—Alimemazine—HRH1—atherosclerosis	0.000301	0.0446	CrCbGaD
Prochlorperazine—Pruritus—Lovastatin—atherosclerosis	0.0003	0.00293	CcSEcCtD
Prochlorperazine—Pruritus—Ezetimibe—atherosclerosis	0.000294	0.00287	CcSEcCtD
Prochlorperazine—Hypersensitivity—Simvastatin—atherosclerosis	0.000292	0.00286	CcSEcCtD
Prochlorperazine—Urticaria—Niacin—atherosclerosis	0.000289	0.00283	CcSEcCtD
Prochlorperazine—Body temperature increased—Niacin—atherosclerosis	0.000288	0.00281	CcSEcCtD
Prochlorperazine—Urticaria—Pravastatin—atherosclerosis	0.000285	0.00278	CcSEcCtD
Prochlorperazine—Body temperature increased—Pravastatin—atherosclerosis	0.000284	0.00277	CcSEcCtD
Prochlorperazine—Pruritus—Simvastatin—atherosclerosis	0.000281	0.00274	CcSEcCtD
Prochlorperazine—Dizziness—Lovastatin—atherosclerosis	0.00028	0.00274	CcSEcCtD
Prochlorperazine—Dizziness—Ezetimibe—atherosclerosis	0.000275	0.00269	CcSEcCtD
Prochlorperazine—Cyclizine—HRH1—atherosclerosis	0.000269	0.0398	CrCbGaD
Prochlorperazine—Hypersensitivity—Niacin—atherosclerosis	0.000268	0.00262	CcSEcCtD
Prochlorperazine—Rash—Lovastatin—atherosclerosis	0.000267	0.00261	CcSEcCtD
Prochlorperazine—Dermatitis—Lovastatin—atherosclerosis	0.000267	0.00261	CcSEcCtD
Prochlorperazine—Headache—Lovastatin—atherosclerosis	0.000266	0.0026	CcSEcCtD
Prochlorperazine—Hypersensitivity—Pravastatin—atherosclerosis	0.000264	0.00258	CcSEcCtD
Prochlorperazine—Dizziness—Simvastatin—atherosclerosis	0.000262	0.00256	CcSEcCtD
Prochlorperazine—Rash—Ezetimibe—atherosclerosis	0.000262	0.00256	CcSEcCtD
Prochlorperazine—Dermatitis—Ezetimibe—atherosclerosis	0.000262	0.00256	CcSEcCtD
Prochlorperazine—Headache—Ezetimibe—atherosclerosis	0.000261	0.00255	CcSEcCtD
Prochlorperazine—Mequitazine—HRH1—atherosclerosis	0.000259	0.0384	CrCbGaD
Prochlorperazine—Pruritus—Niacin—atherosclerosis	0.000258	0.00252	CcSEcCtD
Prochlorperazine—Pruritus—Pravastatin—atherosclerosis	0.000254	0.00248	CcSEcCtD
Prochlorperazine—Rash—Simvastatin—atherosclerosis	0.00025	0.00244	CcSEcCtD
Prochlorperazine—Dermatitis—Simvastatin—atherosclerosis	0.00025	0.00244	CcSEcCtD
Prochlorperazine—Headache—Simvastatin—atherosclerosis	0.000249	0.00243	CcSEcCtD
Prochlorperazine—Dizziness—Niacin—atherosclerosis	0.000241	0.00235	CcSEcCtD
Prochlorperazine—Dizziness—Pravastatin—atherosclerosis	0.000237	0.00232	CcSEcCtD
Prochlorperazine—Rash—Niacin—atherosclerosis	0.00023	0.00224	CcSEcCtD
Prochlorperazine—Dermatitis—Niacin—atherosclerosis	0.000229	0.00224	CcSEcCtD
Prochlorperazine—Headache—Niacin—atherosclerosis	0.000228	0.00223	CcSEcCtD
Prochlorperazine—Rash—Pravastatin—atherosclerosis	0.000226	0.00221	CcSEcCtD
Prochlorperazine—Dermatitis—Pravastatin—atherosclerosis	0.000226	0.00221	CcSEcCtD
Prochlorperazine—Headache—Pravastatin—atherosclerosis	0.000225	0.00219	CcSEcCtD
Prochlorperazine—Zuclopenthixol—HRH1—atherosclerosis	0.000214	0.0317	CrCbGaD
Prochlorperazine—Aripiprazole—HRH1—atherosclerosis	0.000198	0.0293	CrCbGaD
Prochlorperazine—Trazodone—HRH1—atherosclerosis	0.000197	0.0291	CrCbGaD
Prochlorperazine—Thiothixene—HRH1—atherosclerosis	0.000185	0.0273	CrCbGaD
Prochlorperazine—Mesoridazine—HRH1—atherosclerosis	0.000182	0.0269	CrCbGaD
Prochlorperazine—Fluphenazine—HRH1—atherosclerosis	0.000159	0.0236	CrCbGaD
Prochlorperazine—Mianserin—HRH1—atherosclerosis	0.000159	0.0236	CrCbGaD
Prochlorperazine—Propiomazine—HRH1—atherosclerosis	0.000153	0.0227	CrCbGaD
Prochlorperazine—Chlorprothixene—HRH1—atherosclerosis	0.000145	0.0215	CrCbGaD
Prochlorperazine—Thioridazine—HRH1—atherosclerosis	0.000137	0.0203	CrCbGaD
Prochlorperazine—Methotrimeprazine—HRH1—atherosclerosis	0.000131	0.0194	CrCbGaD
Prochlorperazine—Promethazine—HRH1—atherosclerosis	0.000129	0.0191	CrCbGaD
Prochlorperazine—Trifluoperazine—HRH1—atherosclerosis	0.000127	0.0189	CrCbGaD
Prochlorperazine—Loxapine—HRH1—atherosclerosis	0.000127	0.0187	CrCbGaD
Prochlorperazine—Perphenazine—HRH1—atherosclerosis	0.000126	0.0186	CrCbGaD
Prochlorperazine—Quetiapine—HRH1—atherosclerosis	0.000124	0.0183	CrCbGaD
Prochlorperazine—Desipramine—HRH1—atherosclerosis	0.000117	0.0174	CrCbGaD
Prochlorperazine—Promazine—HRH1—atherosclerosis	0.000114	0.0168	CrCbGaD
Prochlorperazine—Clozapine—HRH1—atherosclerosis	0.000106	0.0157	CrCbGaD
Prochlorperazine—Chlorpromazine—HRH1—atherosclerosis	0.0001	0.0148	CrCbGaD
Prochlorperazine—Imipramine—HRH1—atherosclerosis	9.95e-05	0.0147	CrCbGaD
Prochlorperazine—Acepromazine—ALB—atherosclerosis	4.43e-05	0.00655	CrCbGaD
Prochlorperazine—Thioproperazine—ALB—atherosclerosis	4.33e-05	0.0064	CrCbGaD
Prochlorperazine—Thiothixene—ALB—atherosclerosis	4.26e-05	0.0063	CrCbGaD
Prochlorperazine—Pipotiazine—ALB—atherosclerosis	4.26e-05	0.0063	CrCbGaD
Prochlorperazine—Clomipramine—ALB—atherosclerosis	3.37e-05	0.00498	CrCbGaD
Prochlorperazine—Chlorpromazine—ALB—atherosclerosis	2.31e-05	0.00342	CrCbGaD
Prochlorperazine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.05e-05	0.000226	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.05e-05	0.000226	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PLG—atherosclerosis	1.05e-05	0.000225	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CCL5—atherosclerosis	1.04e-05	0.000224	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	1.04e-05	0.000223	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.04e-05	0.000223	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.03e-05	0.000222	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PDGFB—atherosclerosis	1.03e-05	0.000222	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PLG—atherosclerosis	1.03e-05	0.000222	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.03e-05	0.000221	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.02e-05	0.00022	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—LPL—atherosclerosis	1.02e-05	0.000219	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.02e-05	0.000219	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.01e-05	0.000218	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SOCS3—atherosclerosis	1.01e-05	0.000217	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AGT—atherosclerosis	1.01e-05	0.000216	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CETP—atherosclerosis	9.93e-06	0.000213	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PRKCG—atherosclerosis	9.92e-06	0.000213	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SOCS3—atherosclerosis	9.91e-06	0.000213	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—APOE—atherosclerosis	9.86e-06	0.000212	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—LEP—atherosclerosis	9.86e-06	0.000212	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CAV1—atherosclerosis	9.77e-06	0.00021	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	9.75e-06	0.00021	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MMP3—atherosclerosis	9.75e-06	0.00021	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—APOA1—atherosclerosis	9.75e-06	0.00021	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IGF2—atherosclerosis	9.71e-06	0.000209	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SPP1—atherosclerosis	9.66e-06	0.000208	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—CXCL8—atherosclerosis	9.62e-06	0.000207	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MMP3—atherosclerosis	9.57e-06	0.000206	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IGF2—atherosclerosis	9.53e-06	0.000205	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—SCARB1—atherosclerosis	9.51e-06	0.000204	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—APOB—atherosclerosis	9.43e-06	0.000203	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MMP3—atherosclerosis	9.42e-06	0.000203	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ESR1—atherosclerosis	9.41e-06	0.000202	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IGF2—atherosclerosis	9.38e-06	0.000202	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.36e-06	0.000201	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—CXCL8—atherosclerosis	9.35e-06	0.000201	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—F2—atherosclerosis	9.3e-06	0.0002	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EDN1—atherosclerosis	9.28e-06	0.000199	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—APOB—atherosclerosis	9.25e-06	0.000199	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CCL5—atherosclerosis	9.2e-06	0.000198	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	9.18e-06	0.000197	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EDN1—atherosclerosis	9.11e-06	0.000196	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—APOB—atherosclerosis	9.11e-06	0.000196	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CCL5—atherosclerosis	9.04e-06	0.000194	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	9.03e-06	0.000194	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—LPL—atherosclerosis	9e-06	0.000194	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—HMGCR—atherosclerosis	8.98e-06	0.000193	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EDN1—atherosclerosis	8.96e-06	0.000193	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PDGFB—atherosclerosis	8.94e-06	0.000192	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CG—atherosclerosis	8.9e-06	0.000191	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CCL5—atherosclerosis	8.89e-06	0.000191	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	8.88e-06	0.000191	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APOA2—atherosclerosis	8.88e-06	0.000191	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALOX15—atherosclerosis	8.88e-06	0.000191	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	8.88e-06	0.000191	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—LPL—atherosclerosis	8.84e-06	0.00019	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ABCG5—atherosclerosis	8.77e-06	0.000189	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PRKCG—atherosclerosis	8.75e-06	0.000188	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AGT—atherosclerosis	8.72e-06	0.000188	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—LPL—atherosclerosis	8.69e-06	0.000187	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PRKCG—atherosclerosis	8.59e-06	0.000185	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—LEP—atherosclerosis	8.55e-06	0.000184	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—APOE—atherosclerosis	8.55e-06	0.000184	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SPP1—atherosclerosis	8.52e-06	0.000183	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—MAPK3—atherosclerosis	8.52e-06	0.000183	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CXCL8—atherosclerosis	8.49e-06	0.000182	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CAV1—atherosclerosis	8.47e-06	0.000182	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—LPA—atherosclerosis	8.47e-06	0.000182	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	8.45e-06	0.000182	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—APOA1—atherosclerosis	8.45e-06	0.000182	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—INS—atherosclerosis	8.42e-06	0.000181	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SPP1—atherosclerosis	8.37e-06	0.00018	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	8.33e-06	0.000179	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CCL2—atherosclerosis	8.29e-06	0.000178	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	8.23e-06	0.000177	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—BGN—atherosclerosis	8.2e-06	0.000176	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	8.2e-06	0.000176	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ESR1—atherosclerosis	8.16e-06	0.000175	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IGF1—atherosclerosis	8.15e-06	0.000175	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APOA5—atherosclerosis	8.12e-06	0.000175	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—F2—atherosclerosis	8.06e-06	0.000173	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ABCA1—atherosclerosis	8e-06	0.000172	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PDGFB—atherosclerosis	7.89e-06	0.00017	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	7.81e-06	0.000168	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PDGFB—atherosclerosis	7.74e-06	0.000167	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SERPINE1—atherosclerosis	7.74e-06	0.000166	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CG—atherosclerosis	7.71e-06	0.000166	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AGT—atherosclerosis	7.7e-06	0.000166	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	7.62e-06	0.000164	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AGT—atherosclerosis	7.56e-06	0.000163	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.55e-06	0.000162	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—APOE—atherosclerosis	7.54e-06	0.000162	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—LEP—atherosclerosis	7.54e-06	0.000162	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CAV1—atherosclerosis	7.47e-06	0.000161	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—APOA1—atherosclerosis	7.46e-06	0.00016	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AGT—atherosclerosis	7.44e-06	0.00016	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—LEP—atherosclerosis	7.41e-06	0.000159	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—APOE—atherosclerosis	7.41e-06	0.000159	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—MAPK3—atherosclerosis	7.39e-06	0.000159	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NOS3—atherosclerosis	7.39e-06	0.000159	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CAV1—atherosclerosis	7.34e-06	0.000158	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—APOA1—atherosclerosis	7.32e-06	0.000157	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—INS—atherosclerosis	7.3e-06	0.000157	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—LEP—atherosclerosis	7.29e-06	0.000157	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—APOE—atherosclerosis	7.29e-06	0.000157	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	7.22e-06	0.000155	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	7.2e-06	0.000155	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ESR1—atherosclerosis	7.2e-06	0.000155	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CCL2—atherosclerosis	7.18e-06	0.000154	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—F2—atherosclerosis	7.11e-06	0.000153	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ESR1—atherosclerosis	7.07e-06	0.000152	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IGF1—atherosclerosis	7.06e-06	0.000152	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—F2—atherosclerosis	6.98e-06	0.00015	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	6.96e-06	0.00015	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—F2—atherosclerosis	6.87e-06	0.000148	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—HMOX1—atherosclerosis	6.86e-06	0.000148	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	6.81e-06	0.000146	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.77e-06	0.000146	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—LIPC—atherosclerosis	6.73e-06	0.000145	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SERPINE1—atherosclerosis	6.71e-06	0.000144	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APOC3—atherosclerosis	6.68e-06	0.000144	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	6.68e-06	0.000144	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—LDLR—atherosclerosis	6.64e-06	0.000143	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	6.58e-06	0.000141	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—APOB—atherosclerosis	6.58e-06	0.000141	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CXCL8—atherosclerosis	6.55e-06	0.000141	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	6.52e-06	0.00014	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CETP—atherosclerosis	6.49e-06	0.00014	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—INS—atherosclerosis	6.44e-06	0.000139	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NOS3—atherosclerosis	6.4e-06	0.000138	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	6.4e-06	0.000138	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GSTM1—atherosclerosis	6.4e-06	0.000138	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CCL2—atherosclerosis	6.34e-06	0.000136	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—AKT1—atherosclerosis	6.33e-06	0.000136	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—INS—atherosclerosis	6.33e-06	0.000136	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	6.3e-06	0.000135	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—LPL—atherosclerosis	6.28e-06	0.000135	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IGF1—atherosclerosis	6.23e-06	0.000134	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL6—atherosclerosis	6.23e-06	0.000134	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—INS—atherosclerosis	6.23e-06	0.000134	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CCL2—atherosclerosis	6.23e-06	0.000134	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.21e-06	0.000134	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	6.13e-06	0.000132	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GPX1—atherosclerosis	6.13e-06	0.000132	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IGF1—atherosclerosis	6.12e-06	0.000132	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	6.02e-06	0.00013	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CD36—atherosclerosis	5.97e-06	0.000128	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MMP9—atherosclerosis	5.93e-06	0.000127	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	5.92e-06	0.000127	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.87e-06	0.000126	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NFKB1—atherosclerosis	5.86e-06	0.000126	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	5.81e-06	0.000125	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MAPK8—atherosclerosis	5.76e-06	0.000124	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—AKT1—atherosclerosis	5.75e-06	0.000124	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	5.72e-06	0.000123	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	5.68e-06	0.000122	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—MTHFR—atherosclerosis	5.65e-06	0.000122	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NOS3—atherosclerosis	5.65e-06	0.000122	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NOS3—atherosclerosis	5.55e-06	0.000119	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PPARA—atherosclerosis	5.55e-06	0.000119	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	5.49e-06	0.000118	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	5.46e-06	0.000117	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL6—atherosclerosis	5.4e-06	0.000116	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AGT—atherosclerosis	5.37e-06	0.000115	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—VEGFA—atherosclerosis	5.32e-06	0.000114	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—STAT3—atherosclerosis	5.27e-06	0.000113	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—APOE—atherosclerosis	5.26e-06	0.000113	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.23e-06	0.000112	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CAV1—atherosclerosis	5.21e-06	0.000112	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—APOA1—atherosclerosis	5.2e-06	0.000112	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	5.14e-06	0.00011	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	5.08e-06	0.000109	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MAPK3—atherosclerosis	5.03e-06	0.000108	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	5.01e-06	0.000108	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	5e-06	0.000107	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	4.98e-06	0.000107	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	4.92e-06	0.000106	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TGFB1—atherosclerosis	4.88e-06	0.000105	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	4.84e-06	0.000104	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	4.84e-06	0.000104	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL6—atherosclerosis	4.77e-06	0.000103	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	4.75e-06	0.000102	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4.75e-06	0.000102	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL6—atherosclerosis	4.68e-06	0.000101	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	4.68e-06	0.000101	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	4.61e-06	9.92e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	4.61e-06	9.9e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PPARG—atherosclerosis	4.58e-06	9.86e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	4.57e-06	9.82e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MMP9—atherosclerosis	4.53e-06	9.75e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—INS—atherosclerosis	4.5e-06	9.67e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.49e-06	9.65e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	4.49e-06	9.65e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MMP9—atherosclerosis	4.45e-06	9.57e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	4.41e-06	9.48e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	4.4e-06	9.47e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	4.4e-06	9.46e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	4.38e-06	9.42e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	4.36e-06	9.38e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	4.33e-06	9.32e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	4.33e-06	9.31e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	4.32e-06	9.28e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APOB—atherosclerosis	4.3e-06	9.24e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	4.26e-06	9.16e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	4.25e-06	9.14e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	4.23e-06	9.11e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.18e-06	8.99e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ALB—atherosclerosis	4.12e-06	8.86e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—LPL—atherosclerosis	4.1e-06	8.83e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	4.07e-06	8.76e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—STAT3—atherosclerosis	4.03e-06	8.67e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GPX1—atherosclerosis	4e-06	8.61e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	4e-06	8.6e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—STAT3—atherosclerosis	3.96e-06	8.51e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—NOS3—atherosclerosis	3.94e-06	8.48e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	3.93e-06	8.46e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CD36—atherosclerosis	3.9e-06	8.39e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	3.89e-06	8.38e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	3.85e-06	8.28e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	3.78e-06	8.13e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	3.74e-06	8.04e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	3.72e-06	8e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.7e-06	7.95e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL6—atherosclerosis	3.68e-06	7.91e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	3.67e-06	7.89e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPARA—atherosclerosis	3.63e-06	7.8e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	3.61e-06	7.76e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.61e-06	7.75e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AGT—atherosclerosis	3.51e-06	7.55e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APOE—atherosclerosis	3.44e-06	7.4e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CAV1—atherosclerosis	3.41e-06	7.33e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APOA1—atherosclerosis	3.4e-06	7.31e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AKT1—atherosclerosis	3.4e-06	7.3e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL6—atherosclerosis	3.19e-06	6.86e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.11e-06	6.68e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPARG—atherosclerosis	3e-06	6.44e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	2.94e-06	6.33e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—INS—atherosclerosis	2.94e-06	6.32e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL6—atherosclerosis	2.82e-06	6.06e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL6—atherosclerosis	2.76e-06	5.95e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL6—atherosclerosis	2.72e-06	5.85e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALB—atherosclerosis	2.69e-06	5.79e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AKT1—atherosclerosis	2.6e-06	5.59e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NOS3—atherosclerosis	2.58e-06	5.54e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AKT1—atherosclerosis	2.55e-06	5.48e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	2.51e-06	5.4e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.36e-06	5.07e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.81e-06	3.9e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.18e-06	2.55e-05	CbGpPWpGaD
